Abstract

Florbetapir-PET imaging was correlated with the presence and density of β-amyloid. These data provide evidence that a molecular imaging procedure can identify β-amyloid pathology in the brains of individuals during life. Additional studies are required to understand the appropriate use of florbetapir-PET imaging in the clinical diagnosis of Alzheimer disease and for the prediction of progression to dementia.

Keywords

MedicineAutopsyPositron emission tomographyPathologyAmyloid (mycology)Senile plaquesPathologicalAlzheimer's diseasePittsburgh compound BNuclear medicineDisease

Related Publications

Publication Info

Year
2011
Type
article
Volume
305
Issue
3
Pages
275-275
Citations
1069
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1069
OpenAlex

Cite This

Christopher M. Clark (2011). Use of Florbetapir-PET for Imaging β-Amyloid Pathology. JAMA , 305 (3) , 275-275. https://doi.org/10.1001/jama.2010.2008

Identifiers

DOI
10.1001/jama.2010.2008